News List

The oral version of Semaglutide was approved for domestic market, and clinical results showed that it can effectively reduce blood sugar and lose weight

On January 26, 2024, the official website of the State Food and Drug Administration showed that the

Semaglutide has a real rival! Lilly's strongest weight-loss drug, tilpotide is approved by the FDA

The FDA approved Tizepatide, developed by Eli Lilly and Company, as a weight loss drug (trade name Z

It can restore 80% hair growth, and Pfizer's new drug for alopecia areata was approved for sale in China, which can treat adolescent alopecia areata

On October 19, 2023, the official website of China's State Drug Administration showed that it ap

155 million dollars! Hengrui Medicine has another innovative drug to go to sea

Hengray Pharmaceutical announced that it has entered into an agreement with Dr. Reddy's Laborato

Bagel Biologics receives approval to initiate Phase I clinical trial of TCR cell therapy

On September 9, 2023, Biosyngen Pte Ltd (hereinafter referred to as "Biosyngen") announced

Researchers at Zhejiang University School of Medicine have revealed that the concept of targeting DDK can improve the efficacy of immunotherapy for liver cancer

Hepatocellular carcinoma is a common and highly aggressive tumor that has been recognized as the sev

On July 14, Bojian's listing application for tofersen injection was accepted.

On April 25, 2023, the FDA accelerated approval of the antisense oligonucleotide therapy tofersen (Q

The annual bleeding rate of patients was reduced by 71%, and Pfizer's marketing application for hemophilia gene therapy was accepted by the FDA

Pfizer, Inc. (NYSE: PFE) today announced that the FDA has accepted a biologics license application (

FDA approves First repeatable drug gene Therapy, $630,000 a Year, for 'most painful diseases'

On May 19, 2023, the FDA approved Beremagene Geperpavec (B-VEC), a topical gene therapy based on the

Wang Ben's team at Zhejiang University developed fluorine-containing polymer assembly drugs to achieve chemotherapeutic-immune cascade cancer therapy

Recently, Wang's research group from the Institute of Translational Medicine of Zhejiang Univers